DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model.

DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model.

他のバージョン（1件）を表示する

Aims To explore the cost-effectiveness of alternative methods of screening family members for hypertrophic cardiomyopathy (HCM), the most common monogenic cardiac disorder and the most frequent cause of sudden cardiac death (SCD) in young people. Methods and results Economic decision model comparing...

書誌詳細
主要な著者:	Wordsworth, S, Leal, J, Blair, E, Legood, R, Thomson, K, Seller, A, Taylor, J, Watkins, H
フォーマット:	Journal article
言語:	English
出版事項:	2010

類似資料

Is DNA testing for hypertrophic cardiomyopathy cost-effective?
著者:: Wordsworth, S, 等
出版事項: (2006)

DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model
著者:: Wordsworth, S, 等
出版事項: (2010)

Evaluation of Clinical Diagnostic Potential of Next Generation Sequencing using Hypertrophic Cardiomyopathy as a Model
著者:: Taylor, J, 等
出版事項: (2010)

A fast-throughput service for Familial Hypertrophic and Dilated Cardiomyopathy using High resolution melt curve analysis on the Lightscanner
著者:: Thistleton, J, 等
出版事項: (2007)

Expansion of a diagnostic service for hypertrophic cardiomyopathy using next generation sequencing
著者:: Reid, S, 等
出版事項: (2011)

Linked genetic modifiers in hypertrophic cardiomyopathy
著者:: Ektisham, J, 等
出版事項: (2004)

Oxford Molecular Genetics Laboratory Cardiomyopathy Service
著者:: Thistleton, J, 等
出版事項: (2006)

Ascertainment strategies and genotype:phenotype correlations in hypertrophic cardiomyopathy.
著者:: Blair, E, 等
出版事項: (2003)

Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion.
著者:: Ashrafian, H, 等
出版事項: (2003)

Identification of a novel mitochondrial DNA mutation in the ND1 gene in 2 patients with hypertrophic cardiomyopathy with restrictive physiology
著者:: Khogali, S, 等
出版事項: (2001)

Early onset malignant hypertrophic cardiomyopathy caused by mutations in MYBPC3
著者:: Carballo, S, 等
出版事項: (2003)

Sudden death in hypertrophic cardiomyopathy.
著者:: Watkins, H
出版事項: (2000)

Myocardial dysfunction in hypertrophic cardiomyopathy.
著者:: Ashrafian, H, 等
出版事項: (2001)

Novel mutations in cardiac MYBPC3 and early onset malignant hypertrophic cardiomyopathy
著者:: Carballo, S, 等
出版事項: (2005)

Novel mutations in cardiac MYBPC3 causing early onset malignant hypertrophic cardiomyopathy
著者:: Carballo, S, 等
出版事項: (2005)

Hypertrophic cardiomyopathy in Noonan Syndrome closely mimics familial hypertrophic cardiomyopathy due to sarcomeric mutations.
著者:: Hudsmith, L, 等
出版事項: (2006)

Double mutations in CIS can confound genotype-phenotype correlations in hypertrophic cardiomyopathy
著者:: Blair, E, 等
出版事項: (2000)

Data-driven modelling of mutational hotspots and in silico predictors in hypertrophic cardiomyopathy
著者:: Waring, A, 等
出版事項: (2020)

Metabolic perturbations in the pathogenesis of hypertrophic cardiomyopathy
著者:: Ashrafian, H, 等
出版事項: (2005)

Eliciting expert opinion for economic models: an applied example.
著者:: Leal, J, 等
出版事項: (2007)

Novel mutations in cardiac MYPBC3 cause early onset malignant hypertrophic cardiomyopathy (HCM)
著者:: Carballo, S, 等
出版事項: (2005)

Mutations in cis can confound genotype-phenotype correlations in hypertrophic cardiomyopathy.
著者:: Blair, E, 等
出版事項: (2001)

The genetics of hypertrophic cardiomyopathy: Teare redux.
著者:: Watkins, H, 等
出版事項: (2008)

Experience in genetic testing of hypertrophic cardiomyopathy using nanopore DNA sequencing
著者:: R. R. Salakhov, 等
出版事項: (2021-11-01)

A novel mutation in phospholamban causes a mixed hypertrophic and dilated cardiomyopathy phenotype with autosomal dominant inheritance
著者:: Carballo, S, 等
出版事項: (2004)

Genetic clues to disease pathways in hypertrophic and dilated cardiomyopathies.
著者:: Watkins, H
出版事項: (2003)

Functional analysis of hypertrophic cardiomyopathy missense mutations in the light meromyosin region of beta myosin heavy chain
著者:: Redwood, C, 等
出版事項: (2003)

Identification of a novel mitochondrial NADH dehydrogenase I (MTND1) gene mutation in two patients with hypertrophic cardiomyopathy
著者:: Khogali, S, 等
出版事項: (2001)

Hypertrophic cardiomyopathy: from molecular and genetic mechanisms to clinical management
著者:: Watkins, H
出版事項: (2001)

Assigning a causal role to genetic variants in hypertrophic cardiomyopathy.
著者:: Watkins, H
出版事項: (2013)

Screening for hypertrophic cardiomyopathy: a cost analysis of echocardiography, cardiac magnetic resonance and genetic testing
著者:: Manning Warren J, 等
出版事項: (2009-01-01)

The prognostic impact of septal myectomy in obstructive hypertrophic cardiomyopathy.
著者:: Watkins, H, 等
出版事項: (2005)

Hypertrophic Cardiomyopathy
著者:: Asra K. Butt, 等
出版事項: (2023-03-01)

Disease pathways and novel therapeutic targets in hypertrophic cardiomyopathy.
著者:: Ashrafian, H, 等
出版事項: (2011)

Cardiac Steatosis Detected in Hypertrophic Cardiomyopathy, Dilated Cardiomyopathy and Aortic Stenosis
著者:: Suttie, J, 等
出版事項: (2011)

Private mitochondrial DNA variants in danish patients with hypertrophic cardiomyopathy.
著者:: Christian M Hagen, 等
出版事項: (2015-01-01)

Hypertrophic cardiomyopathy
著者:: Sarita Gore, 等
出版事項: (2022-01-01)

Hypertrophic Cardiomyopathy
著者:: Polakit Teekakirikul, MD, 等
出版事項: (2021-09-01)

Hypertrophic cardiomyopathy
著者:: Murillo de Oliveira Antunes, 等
出版事項: (2020-04-01)

The Role of Cardiopulmonary Exercise Testing in Hypertrophic Cardiomyopathy
著者:: Lidija Mikic, 等
出版事項: (2023-07-01)